Canada made history by becoming the first G7 nation to legalize cannabis and creating a world-wide multi-billion dollar industry.
Since the Great White North has established itself as an international leader, its impact has been felt around the world, spawning more and more nations to implement progressive legalization laws.
The global movement will only provide more opportunities for Canadian companies to export and expand into new markets.
Come network with over 1500 of Canada’s and the world’s top executives and thought leaders at Canada’s biggest cannabis industry B2B event. The third annual ICBC Vancouver!
The Conference Package
CONFERENCE | EXPO | AFTER PARTY
The Conference Package
Vancouver Early Bird - $399 USD - Conference and After Party on 16 September The International Cannabis Business Conference will be held Monday, 16 September 2019. Tickets include all speaker sessions and exhibitor areas and entry to exclusive after party on Monday night. Ticket purchase is in US Dollars.
Includes Admission to Conference, Expo, and After Party
Vancouver Early Bird - $549 USD - All Inclusive - Access to VIP Reception on 15 September, Conference and After-Party on 16 September The International Cannabis Business conference will be held on Monday, 16 September 2019. All Inclusive tickets include entry to our exclusive VIP Reception on Sunday 15 September, all speaker sessions and exhibitor area on Monday, 16 September and entry to an exclusive private after-party on Monday night. Ticket purchase is in US Dollars.
Includes Admission to VIP Reception, Conference, Expo, After Party
10:00 Local Vancouver, and British Columbia Regulations
Vancouver and BC have a great tradition of pioneering cannabis policies, but regulations pose challenges for the legal market, both for businesses and regulators. This panel will cover the latest regarding local cannabis policies and the hurdles and opportunities of navigating the landscape of a market with such a rich history of unregulated cannabis commerce.
10:45 Upcoming Regulatory Model: Edibles, Topicals, and Extracts
New rules and regulations are coming for various cannabis products. If current regulations have been any guide, overregulation will probably be the norm, creating hurdles for businesses, but also opportunities for those that can best overcome the regulatory obstacles. This panel will provide an overview of upcoming rules and provide a glimpse into the future landscape of what is sure to be a growing sector of the market.
11:30 Mergers and Acquisitions
Consolidation is the norm. Companies are vertically integrating to bring all aspects of their business in-house, purchasing competitors, and finding partners to help them thrive. Whether you are buying, selling, or joining forces, the panel will cover the ins and outs of consolidating to get necessary competitive edges.
12:15 Staying Relevant: Vetting domestic investments to ensure international feasibility
The international cannabis market is full of high-risk investment opportunities, both public and private. As a result of international drug law violations, Canadian companies will face roadblocks as they attempt to export their medicinal cannabis products. With a quarter trillion dollars of public market cap created from the speculation of international trade, there is a lot at stake for both operators and investors alike. To navigate these challenges, Canadian operators will need to adapt their strategies domestically and legally enter the international market when the timing is right. In this session, Nic Easley, CEO of 3C Consulting, LLC™ & Managing Director of Multiverse Capital, walks you through public and private international cannabis investment strategies and shows you how to thoroughly vet opportunities while reducing risk.
14:30 Pros and Cons of Going Public From an Investment and Financial Viewpoint
Is cannabis the next dot-com? Going public can provide an avenue to gain capital that would otherwise be off limits, but there are drawbacks to consider as well. The capital raised can help companies tackle areas necessary for success from research and development to paying down outstanding debt obligations and can generate positive publicity for the business. In exchange for that capital, public companies must make various disclosures and adhere to new regulations, bringing more hurdles, costs and fees. This panel will explore the ups, and the downs, of going public in the cannabis space.
15:00 Canadian Craft Cannabis
Canada has made great strides creating jobs, generating revenue, and leading G7 nations towards ending cannabis prohibition, but one area that can be improved his helping develop a stable craft cannabis industry. Small farmers and compassion clubs, starting in the medical field, helped build the foundation for legal cannabis commerce. Big mergers make headlines but small and medium businesses, especially cultivators, are stifled, if not outright blocked, by burdensome overregulation. This panel will delve into what is being done, and can be done, to help a Canadian craft cannabis community survive and thrive in the legal, regulated market.
15:30 Exporting Internationally
Canada has been the world’s leader in exporting cannabis, but now there’s some competition and there will certainly be more as country after country will start federally legalizing cannabis commerce. How can Canadian companies make inroads into other nations and keep a competitive advantage as Uruguay and Israel have started exporting and more nations will certainly follow suit? This panel will provide a rundown of exporting currently and discuss ways that Great White North companies can continue to be the global export leader.
16:00 Extraction Science and Tech
Cannabis extracts are a growing sector of the cannabis market and we can expect that it will continue to grow as consumers become more familiar with the products and extracts become more tailored to specific customers. This panel will cover the current extraction landscape, including products and techniques and discuss what the future may hold for this sector of the cannabis industry.
16:30 Strategic Partnership
Specialization is a major factor attracting capital and helping grow the Cannabis sector at hyper-speed. As businesses scale, focused models will be a necessity from both economic and regulatory perspectives, allowing companies to position and embed into the Industry value chain alongside other ‘specialists’. Our panel of industry experts will discuss strategy in identifying synergies in prospective strategic partners and offer their insights related to making these significant decisions which can be a determining factor in the survival and ultimate success of your business.
As most folks know by now, a lack of banking services have forced cannabis businesses, including those legal under state law, to deal predominantly in cash due to continued U.S. banking laws that make it nearly impossible to do business with federally chartered financial institutions. There are a few reasons why Canada, the first G7...
As the cannabis legalization movement moves more mainstream, and the industry become more profitable, we shouldn’t be surprised to see former policymakers and elected officials join the business sector. Former Republican Speaker of the House John Boehner has been the most prominent American politician to enter the industry while Vicente Fox, the former president of...
The best chance of the United States has of legalizing cannabis in the near future is passing the STATES Act that would end federal interference with state’s legalization laws as Donald Trump has signaled his support for the measure. Former Representative Dana Rohrabacher has stated his belief that Trump agrees with a states’ rights legalization...
The International Cannabis Business Conference made its first venture into Switzerland last week, with a conference in Zurich, and the event was a raging success. A sincere thanks to all of our speakers, attendees, sponsors and CannaTrade, Europe’s oldest hemp fair, for partnering with us. We are already looking forward to returning to Switzerland next year!...
Politics can make strange bedfellows. It is a cliche, but it is simply the truth, especially in the United States. There aren’t many political issues that progressive Oregon Senators Ron Wyden and Jeff Merkley have in common with conservative Kentucky Senators Randy Paul and Mitch McConnell, yet they combined forces to (re-)legalize hemp across the...